PeopleBio Announces 2-for-1 Reverse Stock Split to Stabilize Share Price and Enhance Corporate Value, No Shareholder Dilution
PeopleBio has decided on a 2-for-1 reverse stock split, doubling the par value from 500 KRW to 1000 KRW. Consequently, the total number of common shares will be halved from 24,320,660 to 12,160,330 shares.
This is a pure stock consolidation, not a capital reduction, so existing shareholders' equity and market capitalization remain unchanged. No dilution or capital inflow occurs.
The company aims to stabilize the stock price and enhance corporate value by maintaining an appropriate number of outstanding shares. Fractional shares resulting from the split will be paid in cash based on the closing price on the listing date.
The reverse split becomes effective on August 5, 2026, with the new shares expected to be listed on August 31, 2026. The schedule may change subject to shareholder meeting approval.
[AI Summary]PeopleBio's reverse stock split aims to boost share price perception and streamline share count but does not alter fundamental shareholder value. While the higher per-share price may appear positive investors should evaluate based on underlying business performance rather than cosmetic changes.